Lundbeckfonden Revenue and Competitors

Claim your profile

Copenhagen, Denmark

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Lundbeckfonden's estimated annual revenue is currently $7.5M per year.(i)
  • Lundbeckfonden's estimated revenue per employee is $111,940

Employee Data

  • Lundbeckfonden has 67 Employees.(i)
  • Lundbeckfonden grew their employee count by 22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M161-23%N/AN/A
#2
$15M18519%N/AN/A
#3
$7.5M6722%N/AN/A
#4
$7.5M876%N/AN/A
#5
$7.5M48-8%N/AN/A
#6
N/A49-9%N/AN/A
#7
$3.5M32-41%N/AN/A
#8
N/A9787%N/AN/A
#9
N/A913%N/AN/A
#10
N/A3N/AN/AN/A

The Lundbeck Foundation is an active industrial Foundation. Hans Lundbeck founded the company H. Lundbeck in 1915. In 1954, his widow, Grete Lundbeck, established the Lundbeck Foundation and transferred her shares in H. Lundbeck to the Foundation as the couple had no heirs. Today H. Lundbeck is a world leader in the development and sales of drugs to treat brain disorders, and the Foundation owns 70% of the company. In 1989 The Lundbeck Foundation acquired its second subsidiary, and today owns 40% of the capital (67% of the votes) in ALK, the world leader in allergy vaccines. In 2011, the Foundation bought 57% of the leading international rescue and assistance company, Falck. In addition to the three subsidiaries, the Foundation owns and manages a portfolio worth approx. DKK 13,9 billion via Lundbeckfonden Invest, as well as a portfolio of biotech investments managed by Lundbeckfonden Ventures. Lundbeckfonden Emerge, is a strategic initiative to accelerate commercialization of early scientific opportunities through investment and active project involvement. The Foundation annually grants DKK 400-500 million to independent scientific research of the highest international quality. Euro 1 million goes to "The Brain Prize" awarded by Grete Lundbeck's European Brain Research Foundation. It is the Foundation's vision to create better lives through new knowledge.

keywords:N/A

N/A

Total Funding

67

Number of Employees

$7.5M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Lundbeckfonden News

2022-04-13 - SNIPR BIOME Initiates First-in-Human Clinical Trial with ...

In March 2019, SNIPR BIOME closed a $50 million Series A financing by Lundbeckfonden Emerge (Copenhagen), Life Sciences Partners (Amsterdam)...

2019-09-12 - Biopharmaceutical Company Imara Inc. Files Confidentially for ...

... with participation from RA Capital, Rock Springs Capital, Alexandria Venture Investments, Bay City Capital, Lundbeckfonden Ventures, New ...

2019-06-24 - AFYX Therapeutics Closes $13 Million Convertible Loan Financing

Sofinnova Ventures led the investment, with Novo Seeds and Lundbeckfonden Emerge also participating. Proceeds will be used to support the ...

2019-03-11 - Denmark's SNIPR Biome Launches to Merge CRISPR With ...

The financing was led by existing investor Lundbeckfonden Emerge in Copenhagen and LSP in Amsterdam, along with North-East Family ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M6884%N/A
#2
$3.5M6957%N/A
#3
$17.5M72-3%N/A
#4
$7.5M7218%N/A
#5
$7.5M73115%N/A